Clinical Trials in Casablanca, Morocco
3 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
End Stage Renal DiseasePrimary Hyperoxaluria Type 1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company28 enrolled18 locationsNCT04580420
Recruiting
Hypertension Registry: Study of Primary and Secondary Hypertension Phenotypes, Complications, and Treatment Personalization.
Arterial Hypertension
Moroccan Society of Cardiology10,000 enrolled5 locationsNCT06769269